TherapeuticsMD, Inc. (TXMD)
$1.96-2.97%Close
SELLRECOVERY · day 61
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $23M
- Beta
- 0.65
- P/E (TTM)
- -104.26
- Short % float
- 0.22%
- Days to cover
- 1.4
- SI change
- -10.5%
- 1W
- -2.97%
- 1M
- -9.26%
- vs SPY 1W
- -2.83%
- vs SPY 1M
- -11.77%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 35
- VALUE
- 27
- GROWTH
- 35
- GARP
- 72
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-0.5%
REV YoY-
ROE-0.8%
EPS YoY-
ROA-0.6%
GROSS90
OP-118
NET-7
[VALUATION]
P/E TTM-104.26
P/E FWD11.67
SECTOR PE20.34
INDUSTRY PE19.31
P/B0.84
P/FCF-
EV/EBITDA-4.81
EV/EBIT-
PEG0.99
FCF YIELD-
RISK
INT COV-
D/E20.49
ALTMAN Z-
CURR RATIO3.22
ND/EBITDA-
BETA0.65
Company news
FAQ
- What is LOPJLB’s current signal on TXMD?
- LOPJLB’s latest quantitative signal on TherapeuticsMD, Inc. (TXMD) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is TXMD in?
- TherapeuticsMD, Inc. (TXMD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does TherapeuticsMD, Inc. (TXMD) do?
- TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical hormone replacement therapy combining 17Ã-estradiol and progesterone, used to alleviate moderate to severe vasomotor symptoms; and ANNOVERA, an innovative vaginal ring designed for contraception.…